Amgen, Inc. is recalling 572,370 vials of Neupogen (filgrastim) For Injection because stability testing indicates the medication may not maintain its required specifications through its 36-month expiration date. This recall involves 300 mcg/1 mL and 480 mcg/1.6 mL single-dose vials that were distributed across the United States and multiple international countries. If you use this medication, you should consult your doctor or pharmacist to determine if your specific supply is affected and to discuss your ongoing treatment plan.
The drug may lose potency or fall out of required quality standards sooner than the expiration date printed on the package. This could mean the medication is less effective than intended by the time it is administered to a patient.
You have 2 options:
Quantity: 313,620 Vials. Recall #: D-0285-2025.
Quantity: 258,750 Vials. Recall #: D-0286-2025.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.